J S Benner

Summary

Affiliation: Harvard University
Country: USA

Publications

  1. ncbi request reprint Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective
    Joshua S Benner
    ValueMedics Research, LLC, Arlington, VA, and University of Maryland, Baltimore, MD, USA
    Value Health 8:618-28. 2005
  2. pmc A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile
    J S Benner
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Int J Clin Pract 62:1484-98. 2008
  3. ncbi request reprint Long-term persistence in use of statin therapy in elderly patients
    Joshua S Benner
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 221 Longwood Ave, Suite 341, Boston, MA 02115, USA
    JAMA 288:455-61. 2002
  4. ncbi request reprint Adherence
    JoAnne M Foody
    Yale University School of Medicine, Section of Cardiovascular Medicine, New Haven, CT, USA
    J Clin Hypertens (Greenwich) 9:271-5. 2007
  5. ncbi request reprint Predictors of adherence with antihypertensive and lipid-lowering therapy
    Richard H Chapman
    ValueMedics Research, LLC, Arlington, VA, USA
    Arch Intern Med 165:1147-52. 2005
  6. ncbi request reprint Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
    Joshua S Benner
    ValueMedics Research, LLC, Arlington, Virginia, USA
    Pharmacoeconomics 22:13-23. 2004
  7. ncbi request reprint Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030 Boston, MA 02120, USA
    J Ment Health Policy Econ 7:77-85. 2004
  8. ncbi request reprint How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 13:11-9. 2004
  9. ncbi request reprint Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with human immunodeficiency virus
    Julie Munakata
    ValueMedics Research, LLC, Falls Church, VA 22046, USA
    Med Care 44:893-9. 2006
  10. ncbi request reprint Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study
    JoAnne M Foody
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02130, USA
    Curr Med Res Opin 24:1987-2000. 2008

Detail Information

Publications14

  1. ncbi request reprint Cost-effectiveness of rosuvastatin compared with other statins from a managed care perspective
    Joshua S Benner
    ValueMedics Research, LLC, Arlington, VA, and University of Maryland, Baltimore, MD, USA
    Value Health 8:618-28. 2005
    ..The objective of this study was to identify the most cost-effective statin or combination of statins, from the perspective of a managed care payer...
  2. pmc A novel programme to evaluate and communicate 10-year risk of CHD reduces predicted risk and improves patients' modifiable risk factor profile
    J S Benner
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Int J Clin Pract 62:1484-98. 2008
    ..We assessed whether a novel programme to evaluate/communicate predicted coronary heart disease (CHD) risk could lower patients' predicted Framingham CHD risk vs. usual care...
  3. ncbi request reprint Long-term persistence in use of statin therapy in elderly patients
    Joshua S Benner
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 221 Longwood Ave, Suite 341, Boston, MA 02115, USA
    JAMA 288:455-61. 2002
    ....
  4. ncbi request reprint Adherence
    JoAnne M Foody
    Yale University School of Medicine, Section of Cardiovascular Medicine, New Haven, CT, USA
    J Clin Hypertens (Greenwich) 9:271-5. 2007
  5. ncbi request reprint Predictors of adherence with antihypertensive and lipid-lowering therapy
    Richard H Chapman
    ValueMedics Research, LLC, Arlington, VA, USA
    Arch Intern Med 165:1147-52. 2005
    ..This study was undertaken to describe the patterns and predictors of adherence with concomitant antihypertensive (AH) and lipid-lowering (LL) therapy...
  6. ncbi request reprint Follow-up lipid tests and physician visits are associated with improved adherence to statin therapy
    Joshua S Benner
    ValueMedics Research, LLC, Arlington, Virginia, USA
    Pharmacoeconomics 22:13-23. 2004
    ..The objective of this study was to determine whether lipid tests and physician visits after treatment initiation are indeed associated with adherence to statin therapy...
  7. ncbi request reprint Should clozapine continue to be restricted to third-line status for schizophrenia?: a decision-analytic model
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women s Hospital, 1620 Tremont Street, Suite 3030 Boston, MA 02120, USA
    J Ment Health Policy Econ 7:77-85. 2004
    ..Clozapine is currently restricted to patients who have failed at least two trials of other antipsychotic medications because of concerns that its use as a first-line agent would lead to greater mortality, mainly through agranulocytosis...
  8. ncbi request reprint How well do patients report noncompliance with antihypertensive medications?: a comparison of self-report versus filled prescriptions
    Philip S Wang
    Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
    Pharmacoepidemiol Drug Saf 13:11-9. 2004
    ..Although self-reports are often the only means available in routine practice, their accuracy and agreement with other data sources remain questionable...
  9. ncbi request reprint Clinical and economic outcomes of nonadherence to highly active antiretroviral therapy in patients with human immunodeficiency virus
    Julie Munakata
    ValueMedics Research, LLC, Falls Church, VA 22046, USA
    Med Care 44:893-9. 2006
    ..This study aimed to quantify the clinical and economic effects of nonadherence and estimate the cost-effectiveness of improving adherence in treatment-naive HIV patients...
  10. ncbi request reprint Persistence of atorvastatin and simvastatin among patients with and without prior cardiovascular diseases: a US managed care study
    JoAnne M Foody
    Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02130, USA
    Curr Med Res Opin 24:1987-2000. 2008
    ..Therefore, we assessed patient persistence with atorvastatin and simvastatin in primary and secondary prevention patients enrolled in managed care...
  11. ncbi request reprint Rationale, design, and methods for the risk evaluation and communication health outcomes and utilization trial (REACH OUT)
    Joshua S Benner
    ValueMedics Research, LLC, Falls Church, VA 22046, USA
    Contemp Clin Trials 28:662-73. 2007
    ....
  12. ncbi request reprint Gauging the treatment gap in dyslipidemia: findings from the 1999-2000 National Health and Nutrition Examination Survey
    David Klingman
    ValueMedics Research, LLC, Arlington, VA, USA
    Am Heart J 150:595-601. 2005
    ..Despite published guidelines and availability of many effective lipid-altering therapies, dyslipidemia in the United States remains largely underdiagnosed and undertreated...
  13. ncbi request reprint Association between short-term effectiveness of statins and long-term adherence to lipid-lowering therapy
    Joshua S Benner
    ValueMedics Research, LLC, Falls Church, VA 22406, USA
    Am J Health Syst Pharm 62:1468-75. 2005
    ..The relationship between low-density lipoprotein (LDL) cholesterol reduction in the first 3 months of statin therapy and medication adherence during a 33-month follow-up period was studied...
  14. ncbi request reprint Correction: cost-effectiveness of statins in older patients with myocardial infarction
    David A Ganz
    Ann Intern Med 136:635. 2002